X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
index medicus (57) 57
pulmonary disease, chronic obstructive - drug therapy (47) 47
respiratory system (44) 44
tiotropium (44) 44
obstructive pulmonary-disease (42) 42
lung diseases, obstructive (38) 38
pulmonary disease, chronic obstructive - physiopathology (34) 34
treatment outcome (31) 31
efficacy (30) 30
chronic obstructive pulmonary disease (28) 28
safety (27) 27
copd (26) 26
drug therapy (26) 26
muscarinic antagonists - adverse effects (25) 25
administration, inhalation (23) 23
once-daily nva237 (23) 23
bronchodilator agents - administration & dosage (22) 22
bronchodilator agents - adverse effects (22) 22
female (22) 22
muscarinic antagonists - administration & dosage (22) 22
pulmonary disease, chronic obstructive - diagnosis (22) 22
bronchodilator agents - therapeutic use (21) 21
double-blind (21) 21
glycopyrrolate - adverse effects (21) 21
male (21) 21
glycopyrrolate - administration & dosage (20) 20
middle aged (20) 20
lung - drug effects (19) 19
lung - physiopathology (19) 19
indacaterol (18) 18
pharmacology & pharmacy (18) 18
diseases of the respiratory system (17) 17
glycopyrronium (17) 17
international journal of chronic obstructive pulmonary disease (17) 17
muscarinic antagonists - therapeutic use (17) 17
aged (16) 16
glycopyrrolate - therapeutic use (16) 16
review (16) 16
severity of illness index (16) 16
drug administration schedule (15) 15
forced expiratory volume (14) 14
quality of life (14) 14
placebo (13) 13
time factors (13) 13
twice-daily salmeterol (13) 13
daily aclidinium bromide (12) 12
dosage and administration (12) 12
double-blind method (12) 12
drug therapy, combination (12) 12
exacerbations (12) 12
glycopyrrolate (12) 12
lama (12) 12
once-daily indacaterol (12) 12
respiratory tract diseases (12) 12
formoterol (11) 11
patient outcomes (11) 11
pulmonary and respiratory medicine (11) 11
drug combinations (10) 10
long-acting muscarinic antagonist (10) 10
recovery of function (10) 10
bronchodilation (9) 9
care and treatment (9) 9
exercise tolerance (9) 9
indans - administration & dosage (9) 9
indans - therapeutic use (9) 9
original research (9) 9
pulmonary/respiratory (9) 9
quinolones - administration & dosage (9) 9
quinolones - therapeutic use (9) 9
qva149 (9) 9
tiotropium bromide (9) 9
trial (9) 9
adrenergic beta-2 receptor agonists - administration & dosage (8) 8
adrenergic beta-2 receptor agonists - adverse effects (8) 8
adult (8) 8
glycopyrrolate - analogs & derivatives (8) 8
lung-function (8) 8
mortality (8) 8
once-daily tiotropium (8) 8
research (8) 8
risk factors (8) 8
aclidinium (7) 7
adrenergic beta-2 receptor agonists - therapeutic use (7) 7
bronchodilator agents - pharmacokinetics (7) 7
cross-over studies (7) 7
daily nva237 (7) 7
glycopyrrolate - pharmacokinetics (7) 7
muscarinic antagonists - pharmacology (7) 7
spirometry (7) 7
analysis (6) 6
bronchodilator agents - pharmacology (6) 6
clinical trials (6) 6
combination (6) 6
copd patients (6) 6
dyspnea - drug therapy (6) 6
fixed-dose combination (6) 6
fixed-dose combinations (6) 6
forced expiratory volume - drug effects (6) 6
glycopyrrolate - pharmacology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 12/2013, Volume 42, Issue 6, pp. 1484 - 1494
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and glycopyrronium, tiotropium and placebo in... 
ONCE-DAILY NVA237 | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | METAANALYSIS | SAFETY | RESPIRATORY SYSTEM | TIOTROPIUM | RISK | COMBINATION | FLUTICASONE | COPD
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2014, Volume 108, Issue 4, pp. 584 - 592
Summary Introduction QVA149 is a novel, inhaled, once-daily dual bronchodilator containing a fixed-dose combination of the long-acting β2 -agonist indacaterol... 
Pulmonary/Respiratory | QVA149 | Tiotropium | Chronic obstructive pulmonary disease | Exercise | Hyperinflation | PLACEBO | CARDIAC & CARDIOVASCULAR SYSTEMS | DAILY NVA237 | EFFICACY | SAFETY | BRONCHODILATION | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TWICE-DAILY SALMETEROL | ONCE-DAILY INDACATEROL | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Exercise Tolerance - drug effects | Indans - therapeutic use | Lung Volume Measurements | Vital Capacity - drug effects | Quinolones - adverse effects | Spirometry - methods | Quinolones - therapeutic use | Adult | Female | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Tiotropium Bromide | Glycopyrrolate - adverse effects | Double-Blind Method | Drug Administration Schedule | Glycopyrrolate - therapeutic use | Treatment Outcome | Glycopyrrolate - analogs & derivatives | Cross-Over Studies | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Aged | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Medical research | Lung diseases, Obstructive | Confidence intervals | Drug therapy
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2013, Volume 107, Issue 10, pp. 1558 - 1567
Journal Article
Journal Article
Current Medical Research & Opinion, ISSN 0300-7995, 3/2014, Volume 30, Issue 3, pp. 493 - 508
Abstract Background: Glycopyrronium is a once daily (o.d.) long-acting muscarinic antagonist that is approved for maintenance treatment of COPD. This post-hoc... 
Bronchodilation | Exacerbations | LAMA | Glycopyrronium | Once daily | MEDICINE, RESEARCH & EXPERIMENTAL | DAILY NVA237 | EFFICACY | SAFETY | PREVENTION | TRIAL | MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | TIOTROPIUM | PATIENT | Drug Administration Schedule | Glycopyrrolate - therapeutic use | Glycopyrrolate - administration & dosage | Humans | Middle Aged | Placebos | Adult | Female | Male
Journal Article
BMC Pulmonary Medicine, ISSN 1471-2466, 12/2012, Volume 12, Issue 1, pp. 74 - 74
Journal Article